Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 3Radiation Injuries 1Prostatic Neoplasms 1Ovarian Neoplasms 1Noonan Syndrome 1Neurofibromatosis 1 1Leukemia, Myeloid, Acute 1Cognition Disorders 1Carcinoma, Ovarian Epithelial 1Breast Carcinoma In Situ 1

Interventions

Radiotherapy 6Cisplatin 3Paclitaxel 2Carboplatin 2Amifostine 2Sodium Chloride 1Selenomethionine 1Radiation Dose Hypofractionation 1Radiation 1Neck Dissection 1Mental Status and Dementia Tests 1Lovastatin 1Lithium Carbonate 1Lithium 1Linseed Oil 1Glutamine 1G(M1) Ganglioside 1Fibroblast Growth Factor 7 1Electroacupuncture 1Diet Therapy 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Radiation Injuries × Lovastatin × Clear all
NCT00902668 2013-06-20

Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast Cancer

Virginia Commonwealth University

Phase 2 Terminated
3 enrolled 4 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡